XML 61 R13.htm IDEA: XBRL DOCUMENT v3.22.4
Balance Sheet Details
12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Details

4. Balance Sheet Details

Property and Equipment, Net

Property and equipment, net as of December 31, 2022 and 2021 consisted of the following:

 

 

 

December 31,

 

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Furniture and equipment

 

$

1,608

 

 

$

1,619

 

Computers and computer software

 

 

416

 

 

 

430

 

Lab equipment

 

 

13,100

 

 

 

9,453

 

Leasehold improvements

 

 

1,353

 

 

 

 

Total property and equipment

 

 

16,477

 

 

 

11,502

 

Less: accumulated depreciation and amortization

 

 

(6,117

)

 

 

(3,548

)

Property and equipment, net

 

$

10,360

 

 

$

7,954

 

 

Depreciation and amortization expense for the years ended December 31, 2022, 2021 and 2020 was $2.6 million, $1.8 million and $1.4 million respectively.

Accrued Expenses

Accrued expenses as of December 31, 2022 and 2021 consisted of the following:

 

 

 

December 31,

 

 

 

2022

 

 

2021(2)

 

 

 

(in thousands)

 

Clinical studies

 

$

1,518

 

 

$

453

 

Other research and development (1)

 

 

12,446

 

 

 

4,676

 

Other accrued expenses

 

 

1,411

 

 

 

3,658

 

Total

 

$

15,375

 

 

$

8,787

 

______________

(1)
Includes $5.0 million and $0 of accrued manufacturing rights as of December 31, 2022 and 2021, respectively. See Note 6, "Commitments and Contingencies, Sutro Option Agreement," for further details.
(2)
The breakout and categorizations of the 2021 total accrued expenses have been updated to conform to the 2022 presentation.